Target Binding Site Detail
| Target General Information | Top | ||||
|---|---|---|---|---|---|
| Target ID | T72702 | Target Info | |||
| Target Name | Tissue factor (F3) | ||||
| Synonyms | Thromboplastin; TF; F3; Coagulation factor III; CD142 antigen | ||||
| Target Type | Successful Target | ||||
| Gene Name | F3 | ||||
| UniProt ID | |||||
| Ligand General Information | Top | ||||
|---|---|---|---|---|---|
| Ligand Name | alpha-L-Fucose | Ligand Info | |||
| Canonical SMILES | CC1C(C(C(C(O1)O)O)O)O | ||||
| InChI | 1S/C6H12O5/c1-2-3(7)4(8)5(9)6(10)11-2/h2-10H,1H3/t2-,3+,4+,5-,6+/m0/s1 | ||||
| InChIKey | SHZGCJCMOBCMKK-SXUWKVJYSA-N | ||||
| PubChem Compound ID | 439554 | ||||
| Drug Binding Sites of Target | Top | |||||
|---|---|---|---|---|---|---|
| PDB ID: 4YLQ Crystal Structure of a FVIIa-Trypsin Chimera (FT) in Complex with Soluble Tissue Factor | ||||||
| Method | X-ray diffraction | Resolution | 1.40 Å | Mutation | Yes | [1] |
| PDB Sequence |
SGTTNTVAAY
10 NLTWKSTNFK20 TILEWEPKPV30 NQVYTVQIST40 KSGDWKSKCF50 YTTDTECDLT 60 DEIVKDVKQT70 YLARVFSYPA80 GNVESTGSAG90 EPLYENSPEF100 TPYLETNLGQ 110 PTIQSFEQVG120 TKVNVTVEDE130 RTLVRRNNTF140 LSLRDVFGKD150 LIYTLYYWKS 160 SSSGKKTAKT170 NTNEFLIDVD180 KGENYCFSVQ190 AVIPSRTVNR200 KSTDSPVECM 210
|
|||||
|
|
||||||
| PDB ID: 4IBL Rubidium Sites in Blood Coagulation Factor VIIa | ||||||
| Method | X-ray diffraction | Resolution | 1.80 Å | Mutation | No | [2] |
| PDB Sequence |
TVAAYNLTWK
15 STNFKTILEW25 EPKPVNQVYT35 VQISTKSGDW45 KSKCFYTTDT55 ECDLTDEIVK 65 DVKQTYLARV75 FSYPAGNGEP92 LYENSPEFTP102 YLETNLGQPT112 IQSFEQVGTK 122 VNVTVEDERT132 LVRRNNTFLS142 LRDVFGKDLI152 YTLYYWKSSS162 SGKKTAKTNT 172 NEFLIDVDKG182 ENYCFSVQAV192 IPSRTVNRKS202 TDSPVECM
|
|||||
|
|
||||||
| PDB ID: 4ZMA Crystal Structure of a FVIIa-Trypsin Chimera (ST) in Complex with Soluble Tissue Factor | ||||||
| Method | X-ray diffraction | Resolution | 2.30 Å | Mutation | Yes | [1] |
| PDB Sequence |
TNTVAAYNLT
13 WKSTNFKTIL23 EWEPKPVNQV33 YTVQISTKSG43 DWKSKCFYTT53 DTECDLTDEI 63 VKDVKQTYLA73 RVFSYPAGEP92 LYENSPEFTP102 YLETNLGQPT112 IQSFEQVGTK 122 VNVTVEDERT132 LVRRNNTFLS142 LRDVFGKDLI152 YTLYYWKSSS162 SGKKTAKTNT 172 NEFLIDVDKG182 ENYCFSVQAV192 IPSRTVNRKS202 TDSPVECM
|
|||||
|
|
||||||
| PDB ID: 1WTG Human Factor Viia-Tissue Factor Complexed with ethylsulfonamide-D-biphenylalanine-Gln-p-aminobenzamidine | ||||||
| Method | X-ray diffraction | Resolution | 2.20 Å | Mutation | Yes | [3] |
| PDB Sequence |
TVAAYNLTWK
15 STNFKTILEW25 EPKPVNQVYT35 VQISTKSGDW45 KSKCFYTTDT55 ECDLTDEIVK 65 DVKQTYLARV75 FSYPEPLYEN96 SPEFTPYLET106 NLGQPTIQSF116 EQVGTKVNVT 126 VEDERTLVRR136 NNTFLSLRDV146 FGKDLIYTLY156 YWKSGKKTAK169 TNTNEFLIDV 179 DKGENYCFSV189 QAVIPSRTVN199 RKSTDSPVEC209 M
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .FUC or .FUC2 or .FUC3 or :3FUC;style chemicals stick;color identity;select .T:131 or .T:140; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
| PDB ID: 2ZWL Human factor viia-tissue factor complexed with highly selective peptide inhibitor | ||||||
| Method | X-ray diffraction | Resolution | 2.20 Å | Mutation | No | [4] |
| PDB Sequence |
TVAAYNLTWK
15 STNFKTILEW25 EPKPVNQVYT35 VQISTKSGDW45 KSKCFYTTDT55 ECDLTDEIVK 65 DVKQTYLARV75 FSYPEPLYEN96 SPEFTPYLET106 NLGQPTIQSF116 EQVGTKVNVT 126 VEDERTLVRR136 NNTFLSLRDV146 FGKDLIYTLY156 YWKSGKKTAK169 TNTNEFLIDV 179 DKGENYCFSV189 QAVIPSRTVN199 RKSTDSPVEC209 M
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .FUC or .FUC2 or .FUC3 or :3FUC;style chemicals stick;color identity;select .T:131 or .T:135 or .T:140; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
| PDB ID: 1WUN Human Factor Viia-Tissue Factor Complexed with ethylsulfonamide-D-Trp-Gln-p-aminobenzamidine | ||||||
| Method | X-ray diffraction | Resolution | 2.40 Å | Mutation | Yes | [5] |
| PDB Sequence |
TVAAYNLTWK
15 STNFKTILEW25 EPKPVNQVYT35 VQISTKSGDW45 KSKCFYTTDT55 ECDLTDEIVK 65 DVKQTYLARV75 FSYPEPLYEN96 SPEFTPYLET106 NLGQPTIQSF116 EQVGTKVNVT 126 VEDERTLVRR136 NNTFLSLRDV146 FGKDLIYTLY156 YWKSGKKTAK169 TNTNEFLIDV 179 DKGENYCFSV189 QAVIPSRTVN199 RKSTDSPVEC209 M
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .FUC or .FUC2 or .FUC3 or :3FUC;style chemicals stick;color identity;select .T:131 or .T:140; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
| PDB ID: 1WQV Human Factor Viia-Tissue Factor Complexed with propylsulfonamide-D-Thr-Met-p-aminobenzamidine | ||||||
| Method | X-ray diffraction | Resolution | 2.50 Å | Mutation | No | [6] |
| PDB Sequence |
TVAAYNLTWK
15 STNFKTILEW25 EPKPVNQVYT35 VQISTKSGDW45 KSKCFYTTDT55 ECDLTDEIVK 65 DVKQTYLARV75 FSYPEPLYEN96 SPEFTPYLET106 NLGQPTIQSF116 EQVGTKVNVT 126 VEDERTLVRR136 NNTFLSLRDV146 FGKDLIYTLY156 YWKSGKKTAK169 TNTNEFLIDV 179 DKGENYCFSV189 QAVIPSRTVN199 RKSTDSPVEC209 M
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .FUC or .FUC2 or .FUC3 or :3FUC;style chemicals stick;color identity;select .T:131 or .T:140; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
| PDB ID: 2ZZU Human Factor VIIA-Tissue Factor Complexed with ethylsulfonamide-D-5-(3-carboxybenzyloxy)-Trp-Gln-p-aminobenzamidine | ||||||
| Method | X-ray diffraction | Resolution | 2.50 Å | Mutation | No | [7] |
| PDB Sequence |
TVAAYNLTWK
15 STNFKTILEW25 EPKPVNQVYT35 VQISTKSGDW45 KSKCFYTTDT55 ECDLTDEIVK 65 DVKQTYLARV75 FSYPEPLYEN96 SPEFTPYLET106 NLGQPTIQSF116 EQVGTKVNVT 126 VEDERTLVRR136 NNTFLSLRDV146 FGKDLIYTLY156 YWKSGKKTAK169 TNTNEFLIDV 179 DKGENYCFSV189 QAVIPSRTVN199 RKSTDSPVEC209 M
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .FUC or .FUC2 or .FUC3 or :3FUC;style chemicals stick;color identity;select .T:131 or .T:140; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
| PDB ID: 1WSS Human Factor Viia-Tissue Factor in Complex with peptide-mimetic inhibitor that has two charged groups in P2 and P4 | ||||||
| Method | X-ray diffraction | Resolution | 2.60 Å | Mutation | No | [8] |
| PDB Sequence |
TVAAYNLTWK
15 STNFKTILEW25 EPKPVNQVYT35 VQISTKSGDW45 KSKCFYTTDT55 ECDLTDEIVK 65 DVKQTYLARV75 FSYPEPLYEN96 SPEFTPYLET106 NLGQPTIQSF116 EQVGTKVNVT 126 VEDERTLVRR136 NNTFLSLRDV146 FGKDLIYTLY156 YWKSGKKTAK169 TNTNEFLIDV 179 DKGENYCFSV189 QAVIPSRTVN199 RKSTDSPVEC209 M
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .FUC or .FUC2 or .FUC3 or :3FUC;style chemicals stick;color identity;select .T:131 or .T:140; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
| PDB ID: 1WV7 Human Factor Viia-Tissue Factor Complexed with ethylsulfonamide-D-5-propoxy-Trp-Gln-p-aminobenzamidine | ||||||
| Method | X-ray diffraction | Resolution | 2.70 Å | Mutation | Yes | [5] |
| PDB Sequence |
TVAAYNLTWK
15 STNFKTILEW25 EPKPVNQVYT35 VQISTKSGDW45 KSKCFYTTDT55 ECDLTDEIVK 65 DVKQTYLARV75 FSYPEPLYEN96 SPEFTPYLET106 NLGQPTIQSF116 EQVGTKVNVT 126 VEDERTLVRR136 NNTFLSLRDV146 FGKDLIYTLY156 YWKSGKKTAK169 TNTNEFLIDV 179 DKGENYCFSV189 QAVIPSRTVN199 RKSTDSPVEC209 M
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .FUC or .FUC2 or .FUC3 or :3FUC;style chemicals stick;color identity;select .T:131 or .T:140; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
| PDB ID: 2ZP0 Human factor viia-tissue factor complexed with benzylsulfonamide-D-ile-gln-P-aminobenzamidine | ||||||
| Method | X-ray diffraction | Resolution | 2.70 Å | Mutation | No | [9] |
| PDB Sequence |
TVAAYNLTWK
15 STNFKTILEW25 EPKPVNQVYT35 VQISTKSGDW45 KSKCFYTTDT55 ECDLTDEIVK 65 DVKQTYLARV75 FSYPEPLYEN96 SPEFTPYLET106 NLGQPTIQSF116 EQVGTKVNVT 126 VEDERTLVRR136 NNTFLSLRDV146 FGKDLIYTLY156 YWKSGKKTAK169 TNTNEFLIDV 179 DKGENYCFSV189 QAVIPSRTVN199 RKSTDSPVEC209 M
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .FUC or .FUC2 or .FUC3 or :3FUC;style chemicals stick;color identity;select .T:131 or .T:135 or .T:140; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
| PDB ID: 6R2W Crystal structure of the super-active FVIIa variant VYT in complex with tissue factor | ||||||
| Method | X-ray diffraction | Resolution | 1.25 Å | Mutation | Yes | [10] |
| PDB Sequence |
SGTTNTVAAY
10 NLTWKSTNFK20 TILEWEPKPV30 NQVYTVQIST40 KSGDWKSKCF50 YTTDTECDLT 60 DEIVKDVKQT70 YLARVFSYPA80 GNVESTGSAG90 EPLYENSPEF100 TPYLETNLGQ 110 PTIQSFEQVG120 TKVNVTVEDE130 RTLVRRNNTF140 LSLRDVFGKD150 LIYTLYYWKS 160 SSSGKKTAKT170 NTNEFLIDVD180 KGENYCFSVQ190 AVIPSRTVNR200 KSTDSPVECM 210
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .FUC or .FUC2 or .FUC3 or :3FUC;style chemicals stick;color identity;select .T:131 or .T:135 or .T:140; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
| PDB ID: 1W0Y tf7a_3771 complex | ||||||
| Method | X-ray diffraction | Resolution | 2.50 Å | Mutation | No | [11] |
| PDB Sequence |
TVAAYNLTWK
15 STNFKTILEW25 EPKVYTVQIS39 TKSGDWKSKC49 FYTTDTECDL59 TDEIVKDVKQ 69 TYLARVFSYP79 EPLYENSPEF100 TPYLETNLGQ110 PTIQSFEQVG120 TKVNVTVEDE 130 RTLVRRNNTF140 LSLRDVFGKD150 LIYTLYYWKS162 SGKKTAKTNT172 NEFLIDVDKG 182 ENYCFSVQAV192 IPSRTVNRKS202 TDSPVECM
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .FUC or .FUC2 or .FUC3 or :3FUC;style chemicals stick;color identity;select .T:135 or .T:140; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
| PDB ID: 1W2K tf7a_4380 complex | ||||||
| Method | X-ray diffraction | Resolution | 3.00 Å | Mutation | No | [11] |
| PDB Sequence |
TVAAYNLTWK
15 STNFKTILEW25 EPKVYTVQIS39 TKSGDWKSKC49 FYTTDTECDL59 TDEIVKDVKQ 69 TYLARVFSYP79 EPLYENSPEF100 TPYLETNLGQ110 PTIQSFEQVG120 TKVNVTVEDE 130 RTLVRRNNTF140 LSLRDVFGKD150 LIYTLYYWKS162 SGKKTAKTNT172 NEFLIDVDKG 182 ENYCFSVQAV192 IPSRTVNRKS202 TDSPVECM
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .FUC or .FUC2 or .FUC3 or :3FUC;style chemicals stick;color identity;select .T:135 or .T:140; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
| PDB ID: 3ELA Crystal structure of active site inhibited coagulation factor VIIA mutant in complex with soluble tissue factor | ||||||
| Method | X-ray diffraction | Resolution | 2.20 Å | Mutation | Yes | [12] |
| PDB Sequence |
TVAAYNLTWK
15 STNFKTILEW25 EPKPVNQVYT35 VQISTKSGDW45 KSKCFYTTDT55 ECDLTDEIVK 65 DVKQTYLARV75 FSYPAGNVES85 TGSAGEPLYE95 NSPEFTPYLE105 TNLGQPTIQS 115 FEQVGTKVNV125 TVEDERTLVR135 RNNTFLSLRD145 VFGKDLIYTL155 YYWKTAKTNT 172 NEFLIDVCFS188 VQAVIPSRTV198 NRKSTDSPVE208 C
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .FUC or .FUC2 or .FUC3 or :3FUC;style chemicals stick;color identity;select .T:131 or .T:140; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
| PDB ID: 4Z6A Crystal Structure of a FVIIa-Trypsin Chimera (YT) in Complex with Soluble Tissue Factor | ||||||
| Method | X-ray diffraction | Resolution | 2.25 Å | Mutation | Yes | [1] |
| PDB Sequence |
TNTVAAYNLT
13 WKSTNFKTIL23 EWEPKPVNQV33 YTVQISTKSG43 DWKSKCFYTT53 DTECDLTDEI 63 VKDVKQTYLA73 RVFSYPAGNV83 GEPLYENSPE99 FTPYLETNLG109 QPTIQSFEQV 119 GTKVNVTVED129 ERTLVRRNNT139 FLSLRDVFGK149 DLIYTLYYWK159 SSSSGKKTAK 169 TNTNEFLIDV179 DKGENYCFSV189 QAVIPSRTVN199 RKSTDSPVEC209 M |
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .FUC or .FUC2 or .FUC3 or :3FUC;style chemicals stick;color identity;select .T:131 or .T:135 or .T:140; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
| PDB ID: 2AER Crystal Structure of Benzamidine-Factor VIIa/Soluble Tissue Factor complex. | ||||||
| Method | X-ray diffraction | Resolution | 1.87 Å | Mutation | Yes | [13] |
| PDB Sequence |
ATVAAYNLTW
14 KSTNFKTILE24 WEPKPVNQVY34 TVQISTKSGD44 WKSKCFYTTD54 TECDLTDEIV 64 KDVKQTYLAR74 VFSYPAGNGE91 PLYENSPEFT101 PYLETNLGQP111 TIQSFEQVGT 121 KVNVTVEDER131 TLVRRNNTFL141 SLRDVFGKDL151 IYTLYYWKTA168 KTNTNEFLID 178 VDKGENYCFS188 VQAVIPSRTV198 NRKSTDSPVE208 CM
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .FUC or .FUC2 or .FUC3 or :3FUC;style chemicals stick;color identity;select .T:131 or .T:140; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
| PDB ID: 1FAK HUMAN TISSUE FACTOR COMPLEXED WITH COAGULATION FACTOR VIIA INHIBITED WITH A BPTI-MUTANT | ||||||
| Method | X-ray diffraction | Resolution | 2.10 Å | Mutation | No | [14] |
| PDB Sequence |
TVAAYNLTWK
15 STNFKTILEW25 EPKPVNQVYT35 VQISTKSGDW45 KSKCFYTTDT55 ECDLTDEIVK 65 DVKQTYLARV75 FSYPAGEPLY94 ENSPEFTPYL104 ETNLGQPTIQ114 SFEQKVNVTV 127 EDERTLVRRN137 NTFLSLRDVF147 GKDLIYTLYY157 WGKKTAKTNT172 NEFLIDVYCF 187 SVQAVIPSRT197 VNRKSTDSPV207 ECM
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .FUC or .FUC2 or .FUC3 or :3FUC;style chemicals stick;color identity;select .T:135 or .T:140; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
| PDB ID: 3TH2 Mg2+ Is Required for Optimal Folding of the Gamma-Carboxyglutamic Acid (Gla) Domains of Vitamin K-Dependent Clotting Factors At Physiological Ca2+ | ||||||
| Method | X-ray diffraction | Resolution | 1.72 Å | Mutation | No | [15] |
| PDB Sequence |
TVAAYNLTWK
15 STNFKTILEW25 EPKPVNQVYT35 VQISTKSGDW45 KSKCFYTTDT55 ECDLTDEIVK 65 DVKQTYLARV75 FSYPAGNGEP92 LYENSPEFTP102 YLETNLGQPT112 IQSFEQVGTK 122 VNVTVEDERT132 LVRRNNTFLS142 LRDVFGKDLI152 YTLYYWKSSS162 SGKKTAKTNT 172 NEFLIDVDKG182 ENYCFSVQAV192 IPSRTVNRKS202 TDSPVECM
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .FUC or .FUC2 or .FUC3 or :3FUC;style chemicals stick;color identity;select .T:131 or .T:140; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
| PDB ID: 2A2Q Complex of Active-site Inhibited Human Coagulation Factor VIIa with Human Soluble Tissue Factor in the Presence of Ca2+, Mg2+, Na+, and Zn2+ | ||||||
| Method | X-ray diffraction | Resolution | 1.80 Å | Mutation | Yes | [13] |
| PDB Sequence |
TVAAYNLTWK
15 STNFKTILEW25 EPKPVNQVYT35 VQISTKSGDW45 KSKCFYTTDT55 ECDLTDEIVK 65 DVKQTYLARV75 FSYPAGNGEP92 LYENSPEFTP102 YLETNLGQPT112 IQSFEQVGTK 122 VNVTVEDERT132 LVRRNNTFLS142 LRDVFGKDLI152 YTLYYWKTAK169 TNTNEFLIDV 179 DKGENYCFSV189 QAVIPSRTVN199 RKSTDSPVEC209 M
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .FUC or .FUC2 or .FUC3 or :3FUC;style chemicals stick;color identity;select .T:131 or .T:135 or .T:140; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
| PDB ID: 3TH4 Mg2+ Is Required for Optimal Folding of the Gamma-Carboxyglutamic Acid (Gla) Domains of Vitamin K-Dependent Clotting Factors At Physiological Ca2+ | ||||||
| Method | X-ray diffraction | Resolution | 1.80 Å | Mutation | No | [16] |
| PDB Sequence |
TVAAYNLTWK
15 STNFKTILEW25 EPKPVNQVYT35 VQISTKSGDW45 KSKCFYTTDT55 ECDLTDEIVK 65 DVKQTYLARV75 FSYPAGNGEP92 LYENSPEFTP102 YLETNLGQPT112 IQSFEQVGTK 122 VNVTVEDERT132 LVRRNNTFLS142 LRDVFGKDLI152 YTLYYWKTAK169 TNTNEFLIDV 179 DKGENYCFSV189 QAVIPSRTVN199 RKSTDSPVEC209 M
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .FUC or .FUC2 or .FUC3 or :3FUC;style chemicals stick;color identity;select .T:131 or .T:140; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
| PDB ID: 2FIR Crystal structure of DFPR-VIIa/sTF | ||||||
| Method | X-ray diffraction | Resolution | 2.00 Å | Mutation | No | [13] |
| PDB Sequence |
TVAAYNLTWK
15 STNFKTILEW25 EPKPVNQVYT35 VQISTKSGDW45 KSKCFYTTDT55 ECDLTDEIVK 65 DVKQTYLARV75 FSYPAGNGEP92 LYENSPEFTP102 YLETNLGQPT112 IQSFEQVGTK 122 VNVTVEDERT132 LVRRNNTFLS142 LRDVFGKDLI152 YTLYYWKTAK169 TNTNEFLIDV 179 DKGENYCFSV189 QAVIPSRTVN199 RKSTDSPVEC209 M
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .FUC or .FUC2 or .FUC3 or :3FUC;style chemicals stick;color identity;select .T:131 or .T:135 or .T:140; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
| PDB ID: 3TH3 Mg2+ Is Required for Optimal Folding of the Gamma-Carboxyglutamic Acid (Gla) Domains of Vitamin K-Dependent Clotting Factors At Physiological Ca2+ | ||||||
| Method | X-ray diffraction | Resolution | 2.70 Å | Mutation | No | [17] |
| PDB Sequence |
TVAAYNLTWK
15 STNFKTILEW25 EPKPVNQVYT35 VQISTKSGDW45 KSKCFYTTDT55 ECDLTDEIVK 65 DVKQTYLARV75 FSYPAGNGEP92 LYENSPEFTP102 YLETNLGQPT112 RTLVRRNNTF 140 LSLRDVFGKD150 LIYTKTNTNE174 CFSVQAVIPS195 RTVNRKSTDS205 PVEC |
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .FUC or .FUC2 or .FUC3 or :3FUC;style chemicals stick;color identity;select .T:131 or .T:140; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
| PDB ID: 2B8O Crystal Structure of Glu-Gly-Arg-Chloromethyl Ketone-Factor VIIa/Soluble Tissue Factor Complex | ||||||
| Method | X-ray diffraction | Resolution | 2.80 Å | Mutation | No | [18] |
| PDB Sequence |
TVAAYNLTWK
15 STNFKTILEW25 EPKPVNQVYT35 VQISTKSGDW45 KSKCFYTTDT55 ECDLTDEIVK 65 DVKQTYLARV75 FSYPAGNGEP92 LYENSPEFTP102 YLETNLGQPT112 IQSFEQVGTK 122 VNVTVEDERT132 LVRRNNTFLS142 LRDVFGKDLI152 YTLYYWKTAK169 TNTNEFLIDV 179 DKGENYCFSV189 QAVIPSRTVN199 RKSTDSPVEC209 M
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .FUC or .FUC2 or .FUC3 or :3FUC;style chemicals stick;color identity;select .T:131 or .T:135 or .T:140; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
| PDB ID: 2PUQ Crystal structure of active site inhibited coagulation factor VIIA in complex with soluble tissue factor | ||||||
| Method | X-ray diffraction | Resolution | 2.05 Å | Mutation | No | [19] |
| PDB Sequence |
TVAAYNLTWK
15 STNFKTILEW25 EPKPVNQVYT35 VQISTKSGDW45 KSKCFYTTDT55 ECDLTDEIVK 65 DVKQTYLARV75 FSYPAGNVES85 TGSAGEPLYE95 NSPEFTPYLE105 TNLGQPTIQS 115 FEQVGTKVNV125 TVEDERTLVR135 RNNTFLSLRD145 VFGKDLIYTL155 YYKTAKTNTN 173 EFLIDVCFSV189 QAVIPSRTVN199 RKSTDSPVEC209
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .FUC or .FUC2 or .FUC3 or :3FUC;style chemicals stick;color identity;select .T:131 or .T:140; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
| PDB ID: 1DAN Complex of active site inhibited human blood coagulation factor VIIA with human recombinant soluble tissue factor | ||||||
| Method | X-ray diffraction | Resolution | 2.00 Å | Mutation | No | [20] |
| PDB Sequence |
EPLYENSPEF
100 TPYLETNLGQ110 PTIQSFEQVG120 TKVNVTVEDE130 RTLVRRNNTF140 LSLRDVFGKD 150 LIYTLYYWSG164 KKTAKTNTNE174 FLIDVDKGEN184 YCFSVQAVIP194 SRTVNRKSTD 204 SPVECM
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .FUC or .FUC2 or .FUC3 or :3FUC;style chemicals stick;color identity;select .U:131 or .U:140; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
| PDB ID: 2EC9 Crystal structure analysis of human Factor VIIa , Souluble tissue factor complexed with BCX-3607 | ||||||
| Method | X-ray diffraction | Resolution | 2.00 Å | Mutation | No | [21] |
| PDB Sequence |
EPLYENSPEF
100 TPYLETNLGQ110 PTIQSFEQVG120 TKVNVTVEDE130 RTLVRRNNTF140 LSLRDVFGKD 150 LIYTLYYWSG164 KKTAKTNTNE174 FLIDVDKGEN184 YCFSVQAVIP194 SRTVNRKSTD 204 SPVECM
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .FUC or .FUC2 or .FUC3 or :3FUC;style chemicals stick;color identity;select .U:131 or .U:140; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
| PDB ID: 2C4F crystal structure of factor VII.stf complexed with pd0297121 | ||||||
| Method | X-ray diffraction | Resolution | 1.72 Å | Mutation | No | [22] |
| PDB Sequence |
EPLYENSPEF
100 TPYLETNLGQ110 PTIQSFEQVG120 TKVNVTVEDE130 RTLVRRNNTF140 LSLRDVFGKD 150 LIYTLYYWSG164 KKTAKTNTNE174 FLIDVDKGEN184 YCFSVQAVIP194 SRTVNRKSTD 204 SPVECM
|
|||||
|
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .FUC or .FUC2 or .FUC3 or :3FUC;style chemicals stick;color identity;select .U:131 or .U:140; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
| References | Top | ||||
|---|---|---|---|---|---|
| REF 1 | Molecular Basis of Enhanced Activity in Factor VIIa-Trypsin Variants Conveys Insights into Tissue Factor-mediated Allosteric Regulation of Factor VIIa Activity. J Biol Chem. 2016 Feb 26;291(9):4671-83. | ||||
| REF 2 | Structure of human factor VIIa-soluble tissue factor with calcium, magnesium and rubidium. doi:10.1107/S2059798321003922. | ||||
| REF 3 | Novel interactions of large P3 moiety and small P4 moiety in the binding of the peptide mimetic factor VIIa inhibitor. Biochem Biophys Res Commun. 2005 Jan 28;326(4):859-65. | ||||
| REF 4 | Human factor viia-tissue factor complexed with highly selective peptide inhibitor | ||||
| REF 5 | Structure-based design of P3 moieties in the peptide mimetic factor VIIa inhibitor. Biochem Biophys Res Commun. 2005 Feb 11;327(2):589-96. | ||||
| REF 6 | Crystal structure of human factor VIIa/tissue factor in complex with peptide mimetic inhibitor. Biochem Biophys Res Commun. 2004 Nov 26;324(4):1227-33. | ||||
| REF 7 | Design and synthesis of peptidomimetic factor VIIa inhibitors. Chem Pharm Bull (Tokyo). 2010 Jan;58(1):38-44. | ||||
| REF 8 | Structure of human factor VIIa/tissue factor in complex with a peptide-mimetic inhibitor: high selectivity against thrombin by introducing two charged groups in P2 and P4. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2005 Feb 1;61(Pt 2):169-73. | ||||
| REF 9 | Peptide Mimetic Factor VIIa Inhibitor: Importance of Hydrophilic Pocket in S2 Site to Improve Selectivity aganist Thrombin | ||||
| REF 10 | Beating tissue factor at its own game: Design and properties of a soluble tissue factor-independent coagulation factor VIIa. J Biol Chem. 2020 Jan 10;295(2):517-528. | ||||
| REF 11 | Design of selective phenylglycine amide tissue factor/factor VIIa inhibitors. Bioorg Med Chem Lett. 2005 Feb 1;15(3):817-22. | ||||
| REF 12 | Mechanism of the Ca2+-induced enhancement of the intrinsic factor VIIa activity. J Biol Chem. 2008 Sep 19;283(38):25863-70. | ||||
| REF 13 | High resolution structures of p-aminobenzamidine- and benzamidine-VIIa/soluble tissue factor: unpredicted conformation of the 192-193 peptide bond and mapping of Ca2+, Mg2+, Na+, and Zn2+ sites in factor VIIa. J Biol Chem. 2006 Aug 25;281(34):24873-88. | ||||
| REF 14 | Structure of extracellular tissue factor complexed with factor VIIa inhibited with a BPTI mutant. J Mol Biol. 1999 Feb 5;285(5):2089-104. | ||||
| REF 15 | Mg2+ Is Required for Optimal Folding of the Gamma-Carboxyglutamic Acid (Gla) | ||||
| REF 16 | Mg2+ Is Required for Optimal Folding of the Gamma-Carboxyglutamic Acid (Gla) | ||||
| REF 17 | Mg2+ Is Required for Optimal Folding of the Gamma-Carboxyglutamic Acid (Gla) | ||||
| REF 18 | Crystal Structure of Factor VIIa/soluble Tissue Factor complexed with Glu-Gly-Arg-Chloromethyl ketone | ||||
| REF 19 | Engineering the substrate and inhibitor specificities of human coagulation Factor VIIa. Biochem J. 2007 Aug 1;405(3):429-38. | ||||
| REF 20 | The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor. Nature. 1996 Mar 7;380(6569):41-6. | ||||
| REF 21 | Probing the S2 site of factor VIIa to generate potent and selective inhibitors: the structure of BCX-3607 in complex with tissue factor-factor VIIa. Acta Crystallogr D Biol Crystallogr. 2007 Jun;63(Pt 6):689-97. | ||||
| REF 22 | The discovery of fluoropyridine-based inhibitors of the factor VIIa/TF complex--Part 2. Bioorg Med Chem Lett. 2006 Feb 15;16(4):1060-4. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.